Technology

Technology stocks are having a particularly rough start in 2022. The tech-centric Nasdaq is down 9.1% year to date while the Dow is down a more modest 2.3%.

High-growth tech stocks typically have lofty earnings expectations built into them. So when investors expect rates to rise and demand to slow, these stocks get hit the hardest.

Investors are also concerned about whether businesses will start to curtail their technological investments after spending big money on upgrades during the pandemic.

On that front, DeSpirito believes the fear is overblown.

“We believe spending will continue as companies need to keep both home and office systems running in the new hybrid work environment.”

DeSpirito says companies will be prompted to spend on efficiency-enhancing technology due to rising labor costs.

Investors should also pay attention to the 5G rollout, as telecom giants continue to invest heavily in cellular network upgrades.

If you don’t want to pick individual winners and losers, an ETF like the Defiance Next Gen Connectivity ETF (FIVG) provides easy access to a diversified portfolio of 5G stocks.

Fundrise helps you invest in real estate without having to buy a house. Let their state-of-the-art technology and in-house experience open the door to new opportunities today.

Sign up

Energy

Energy investors had a big year in 2021, with the Energy Select Sector SPDR ETF (XLE) having returned a whopping 53%.

While past performance is no guarantee of future results, the momentum in energy stocks has continued in 2022. XLE is already up another 20.5% year to date.

DeSpirito remains bullish on energy stocks.

“There is still a significant need for traditional energy as the world transitions to cleaner solutions, and those needs were magnified as the world reopened in the past year,” he wrote. “In this interim period ― amid robust demand, hesitancy to increase supply, and renewables still far from filling the gap ― we can expect higher prices to linger.”

Oil prices remain strong. WTI crude has risen 19% in 2022. And DeSpirito expects exploration and production companies to capitalize.

The big producers are already market darlings. ExxonMobil is up roughly 25% year to date while ConocoPhillips shares have surged nearly 30%.

Financials

DeSpirito likes financials because the sector offers growth at a reasonable price right now.

“The need for excess return in a lower-return world sets the stage for growth in alternative asset managers,” he wrote. “Yet current pricing suggests markets are skeptical, with some of these high-growth-potential alternative managers priced like value stocks.”

Among companies in the financial sector, DeSpirito likes banks the most because of how well they are positioned for the rising interest rate environment.

As interest rates go up, banks’ net interest spread — the difference between the interest they pay to depositors and the interest they earn from loans — typically widens.

If the Fed does indeed tighten up its monetary policy, banks can look forward to improving profitability.

Investors can tap into the sector by owning shares of big individual banks like JPMorgan, Bank of America and Citigroup. Of course, a fund like the SPDR S&P Bank ETF provides convenient access to a portfolio of bank stocks.

While commercial real estate to has always been reserved for a few elite investors, outperforming the S&P 500 over a 25-year period, First National Realty Partners allows you to access institutional-quality commercial real estate investments — without the leg work of finding deals yourself.

Get started

Healthcare

Healthcare serves as a classic example of a defensive sector thanks to its lack of correlation with the ups and downs of the economy.

DeSpirito believes quality stocks in the sector can add a “dose of portfolio resilience.”

Healthcare contains several different industries. Right now, DeSpirito thinks the medical device industry is being overlooked by investors.

“Earnings for many of these companies are modestly depressed as elective procedures had to be delayed. As these come back online, we see plenty of ground to be made up.”

Average investors might find it difficult to pick out specific medical device companies. But ETFs such as the iShares U.S. Medical Devices ETF (IHI) and SPDR S&P Health Care Equipment ETF (XHE) offer diversified ways to invest in the group.

If you’re after more broad exposure to the healthcare sector, an ETF like the Health Care Select Sector SPDR Fund (XLV) should do the trick.

Sign up for our MoneyWise newsletter to receive a steady flow of actionable ideas from Wall Street's top firms.

More from MoneyWise

Pour your portfolio a glass of recession resistance

Fine wine is a sweet comfort in any situation — and now it can make your investment portfolio a little more comfortable, too.

Ownership in real assets like fine wine could be the diversification you need to protect your portfolio against the volatile effects of inflation and recession. High-net-worth investors have kept this secret to themselves for too long.

Now a platform called Vinovest helps everyday buyers invest in fine wines — no sommelier certification required.

Vinovest automatically selects the best wines for your portfolio based on your goals, and it tells you the best times to sell to get the best value for your wine.

About the Author

Jing Pan

Jing Pan

Investment Reporter

Jing is an investment reporter for MoneyWise. Prior to joining the team, he was a research analyst and editor at one of the leading financial publishing companies in North America. An avid advocate of investing for passive income, he wrote a monthly dividend stock newsletter for the better half of the past decade. Jing holds a Master’s Degree in Economics and an Honours Bachelor of Science Degree, both from the University of Toronto.

What to Read Next

Disclaimer

The content provided on MoneyWise is information to help users become financially literate. It is neither tax nor legal advice, is not intended to be relied upon as a forecast, research or investment advice, and is not a recommendation, offer or solicitation to buy or sell any securities or to adopt any investment strategy. Tax, investment and all other decisions should be made, as appropriate, only with guidance from a qualified professional. We make no representation or warranty of any kind, either express or implied, with respect to the data provided, the timeliness thereof, the results to be obtained by the use thereof or any other matter.